Dx
Diagnosis & Cognitive Assessment
Normal aging, MCI, cognitive screening, mental-status examination, neuropsychological testing, functional assessment, staging and differential diagnosis.
Harvard Dementia A Comprehensive Update 2026
Original price was: $1,475.97.$179.97Current price is: $179.97.
Original price was: $1,500.97.$179.97Current price is: $179.97.
Original price was: $107.19.$29.97Current price is: $29.97.
Original price was: $900.97.$149.97Current price is: $149.97.
Original price was: $900.97.$139.97Current price is: $139.97.
Original price was: $89.98.$29.97Current price is: $29.97.
Original price was: $900.97.$149.97Current price is: $149.97.
Total: $179.97
Immediate access to your resources, enabling you to start your learning journey without delay.
At ChidoPhysio, we guarantee affordability. Our prices are always up to 80% lower than other providers, ensuring you receive top-quality Physical therapy books without breaking the bank.
At ChidoPhysio, our dedicated customer support team is here to assist you every step of the way 24/7 . Your questions and concerns are our top priority.
Rest easy knowing that your payment is secure and encrypted when you choose to purchase our dental education resources. We offer trusted payment options, including PayPal and Stripe, to safeguard your financial information. Your privacy and security are our top priorities.
Description
HARVARD • DEMENTIA & COGNITIVE NEUROLOGY • 2026
Dementia: A Comprehensive Update 2026
A multidisciplinary recorded update on cognitive assessment, Alzheimer’s disease and related dementias, biomarkers, neuroimaging, disease-modifying therapies, behavioral symptoms, caregiver support, safety, legal issues, and end-of-life care.
RECORDED COURSE4-DAY PROGRAM29TH ANNUAL UPDATEINSTANT ACCESSLIFETIME ACCESS
2026 Dementia Clinical Update
AD
Alzheimer’s DiseaseDiagnosis, MCI, progression & treatment
BIO
BiomarkersBlood, CSF & clinical integration
IMG
NeuroimagingMRI, FDG-PET, amyloid PET & tau PET
DMT
Disease-Modifying TherapyLecanemab, donanemab & ARIA
BEH
Behavioral CareAgitation, depression, psychosis & sleep
CARE
Caregiving & SafetyCapacity, driving, planning & advanced care
4 DaysComplete Program
29thAnnual Update
3Course Leaders
∞Lifetime Access
About the Course
From early cognitive change to advanced dementia care.
A practical program spanning normal cognitive aging, MCI, dementia diagnosis, biomarker interpretation, treatment, safety and advanced-care planning.
Dementia: A Comprehensive Update 2026 is designed for healthcare professionals who evaluate, manage or investigate cognitive impairment and neurodegenerative disease.
The curriculum integrates cognitive neurology, neuropsychology, neuropathology, blood and CSF biomarkers, structural and molecular neuroimaging, pharmacologic and non-pharmacologic treatment, caregiver support, and practical medico-legal decision-making.
Special emphasis is placed on blood-based biomarkers and newer Alzheimer’s disease-modifying therapies, including candidate selection, treatment monitoring, safety, amyloid-related imaging abnormalities, and case-based discussion of lecanemab and donanemab.
Why clinicians choose this program
Practical evaluation of memory loss, MCI and dementia
Blood, CSF, MRI and PET biomarker updates
Disease-modifying Alzheimer’s treatment strategies
Differential diagnosis across major dementia syndromes
Behavioral and neuropsychiatric symptom management
Caregiver support, safety, legal and end-of-life planning
Core Learning Areas
A complete clinical framework for dementia diagnosis and management.
The course connects cognitive assessment and biomarker interpretation with treatment, family support and long-term planning.
BIO
Biomarkers & Neuroimaging
Blood biomarkers, CSF analysis, MRI, FDG-PET, amyloid PET, tau PET, appropriate use, interpretation and clinical integration.
Tx
Treatment & Behavioral Care
Anti-amyloid therapy, conventional medications, ARIA monitoring, neuropsychiatric symptoms, behavioral strategies and non-pharmacologic care.
CARE
Caregiving, Ethics & Advanced Care
Family counseling, caregiver burden, capacity, finances, driving, independent-living safety, advance planning, palliation and hospice.
Course Leadership
Meet the official 2026 course directors.
Brad Dickerson and Alireza Atri are Course Directors; Lynn Shaughnessy is Associate Course Director.
Course Director
Brad Dickerson, MD
Professor of Neurology, Harvard Medical School
Massachusetts General Hospital
Cognitive neurology, dementia and neuroimaging
Course Director
Alireza Atri, MD, PhD
Cognitive Neurology
Alzheimer’s disease clinical care and therapeutics
Harvard Medical School course faculty
Associate Course Director
Lynn Shaughnessy, PsyD
Instructor in Neurology, Harvard Medical School
Beth Israel Deaconess Medical Center
Neuropsychology and practical compensatory strategies
Additional Expert Faculty
4-Day Curriculum
Diagnosis, biomarkers, therapies, behavior, caregiving and advanced care.
A concise day-by-day overview based on the official 2026 schedule.
Cognition, Biomarkers & Alzheimer’s Disease
- Human cognition and memory systems
- Neuropathology of AD/ADRD
- Proteinopathies and neuroimaging
- Blood biomarkers in 2026
- Practical Alzheimer’s evaluation
- MCI and prodromal disease
- Experimental therapeutics
Dementia Syndromes & Anti-Amyloid Treatment
- Neuropsychology of aging
- Executive and attentional systems
- Frontotemporal dementia
- Aphasia-predominant dementias
- Vascular cognitive impairment
- Lewy body and Parkinsonian dementias
- Lecanemab and donanemab cases
Behavioral Symptoms, Caregiving & Complex Syndromes
- Non-pharmacologic behavioral care
- Pharmacologic symptom management
- Ethical disclosure of diagnosis and risk
- Caregiver burden and support
- Community advocacy
- Chronic traumatic encephalopathy
- Delirium and uncommon dementias
Law, Capacity, Safety & End-of-Life Care
- Dementia and the law
- Testamentary capacity and undue influence
- Mental capacity and competence
- Finances and independent-living safety
- Driving and community safety
- Advance care planning
- Palliation, hospice and end-stage dementia
Who should take this course?
Designed for clinicians and healthcare professionals involved in cognitive, neurologic, psychiatric, geriatric and primary-care evaluation of dementia.
Course Package
Recorded educational access organized for flexible self-paced review.
4 Days
Complete Program
Full 2026 dementia update covering diagnosis, treatment, behavior and advanced care.
Recorded
On-Demand Sessions
Review the available presentations according to your own schedule.
Instant
Access After Purchase
Access your purchased educational materials online after order completion.
∞
Lifetime Access
Return to the available recorded course materials whenever needed.
Frequently Asked Questions
Before you download.
Clear answers to common buyer questions.
Is this a live course?
No. This product contains recorded, on-demand educational materials for independent study.
What topics are covered?
Alzheimer’s disease, MCI, biomarkers, neuroimaging, dementia syndromes, disease-modifying therapies, behavioral symptoms, caregiver support, safety, legal considerations and advanced dementia care.
Are biomarkers and neuroimaging covered?
Yes. Topics include blood and CSF biomarkers, MRI, FDG-PET, amyloid PET and tau PET, with practical clinical interpretation.
Are newer Alzheimer’s treatments discussed?
Yes. The curriculum includes lecanemab, donanemab, candidate selection, monitoring and ARIA.
How will I receive access after purchase?
Access instructions are provided after your order is completed so you can begin reviewing the available materials right away.
Does course access expire?
No. Lifetime access is included with the purchased recorded course materials.
Does this recorded package include CME/CE credit or a certificate?
No. CME/CE credit and an official certificate are not included with this recorded course package.
Important: This product provides recorded, on-demand educational materials and is not registration for the original live Harvard event. No CME/CE credit or official certificate is included with this recorded package.
DEMENTIA • COGNITIVE NEUROLOGY • 2026
A complete clinical update for modern dementia diagnosis and care.
Review cognitive assessment, biomarkers, MRI and PET imaging, Alzheimer’s disease, MCI, related dementias, lecanemab and donanemab, behavioral care, caregiver support, capacity, safety and end-of-life planning — at your own pace.
DOWNLOAD COURSE NOW RECORDED COURSE • 4-DAY PROGRAM • INSTANT ACCESS • LIFETIME ACCESSYou must be logged in to post a review.
Ebooks related to this title
-
PDF
Pediatric Hematology & Oncology Secrets 2nd Edition
Original price was: $71.89.$27.89Current price is: $27.89. Add to cart -
PDF
2025 ACP Internal Medicine Board Review Course – Greater Chicago, IL
Original price was: $1,495.00.$149.97Current price is: $149.97. Add to cart -
PDF
ACP CME 165 2025
Original price was: $1,500.00.$169.97Current price is: $169.97. Add to cart
Reviews
There are no reviews yet.